Business
Novel Food Application
Novel Food Application.
About this update from Chill Brands Group Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 4600U\n Zoetic International PLC\n 06 April 2021\n \n \n \n \n \n \n For immediate release\n \n \n 6 April 2021\n \n \n \n \n THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310\n \n Zoetic International plc\n ('Zoetic', the 'Company' or the 'Group')\n \n \n Zoetic's Novel Food Application passes FSA administrative check\n \n \n \n \n \n Zoetic, the international CBD group, is pleased to provide the following update on its efforts to gain regulatory approval by the UK Food Standards Agency ('FSA' or the 'Agency') for its products in the United Kingdom. This FSA approval is now required for CBD products to be sold in the UK. This applies to all CBD brands and not only those owned by Zoetic.\n \n \n \n \n \n Overview\n \n \n · \n The FSA announced on 13 February 2020 that businesses must submit a novel food authorisation application by 31 March 2021 if they wish to have their CBD products sold in the UK. CBD products without the authorisation and subsequent validation would not be allowed to be sold in the UK.\n \n \n \n \n \n · \n Zoetic submitted an application in conjunction with the European Industrial Hemp Association's ('EIHA') Novel Food Consortium.\n \n \n \n \n \n · \n Zoetic received notification from EIHA that its CBD products passed the regulator's administrative check and can remain on sale in the UK.\n \n \n \n \n \n · \n Official validation will be granted pending the results of toxicological studies on CBD, expected in the coming months.\n \n \n \n \n \n Following the submission of a legal dossier, made in partnership with the EIHA's Novel Food Consortium, the Group has now received confirmation that its natural isolate CBD products can continue to be sold in the UK as the application has passed the regulator's administrative check. Official validation is expected to follow in the coming months, pending the results of toxicological studies of the CBD contained in its products.\n \n \n \n \n \n \n Trevor Taylor, Co-CEO of Zoetic, said\n \n : \"The FSA's regulation marks a pivotal moment for the CBD industry and Zoetic welcomes the Agency's efforts to protect consumers from CBD products that do not meet the necessary standards. We s...